The Multiple Myeloma Channel is supported with funding from BMS (Gold) and Legend Biotech (Bronze).
VJHemOnc is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
COMy 2022 | Providing hope for the future of myeloma treatment – the goal of COMy 2022
Mohamad Mohty, MD, PhD, Saint-Antoine Hospital, Paris, France, promotes the 2022 8th World Congress on Controversies in Multiple Myeloma (COMy), which is focused on collaboration, innovation, and the future of myeloma treatment. This congress will be held both virtually and in Paris, France, on May 12-14, 2022.
Transcript
COMy is about collaboration, but also thinking the future. It’s about giving hope. And the best conclusion to the COMy Congress you would envision, it’s about the requirement for operational cure. A giant like Jean-Luc Harousseau will tackle this big challenge. First relapse is becoming a crucial step in the natural history of multiple myeloma. Another giant, Dr Dimopoulos, will share with you his perspective there...
COMy is about collaboration, but also thinking the future. It’s about giving hope. And the best conclusion to the COMy Congress you would envision, it’s about the requirement for operational cure. A giant like Jean-Luc Harousseau will tackle this big challenge. First relapse is becoming a crucial step in the natural history of multiple myeloma. Another giant, Dr Dimopoulos, will share with you his perspective there. And last but not least, as it is a tradition during COMy, Dr Ken Anderson always is giving us his vision about the future. And this year he will speak about multiple myeloma cure in 2030, guys. So this is COMy. This is about innovation. This is about collaboration. This is about cure for our patients, so please don’t miss it.
Read more...
